BIOMARIN PHARMACEUTICAL INC Amortization of Deferred Loan Origination Fees, Net
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Amortization of Deferred Loan Origination Fees, Net of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredLoanOriginationFeesNet · last filed 2013-02-26
- BIOMARIN PHARMACEUTICAL INC amortization of deferred loan origination fees, net for fiscal 2012 was $0.00.
- BIOMARIN PHARMACEUTICAL INC amortization of deferred loan origination fees, net for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- BIOMARIN PHARMACEUTICAL INC amortization of deferred loan origination fees, net for fiscal 2010 was $1.55M.
| Period end | Amortization of Deferred Loan Origination Fees, Net 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-02-26 |
| 2011-12-31 | $0.00 10-K · filed 2013-02-26 |
| 2010-12-31 | $1.55M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |